All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

Strive Health raised $550 million in a Series D funding round, valuing it at $1.8 billion.

Why it matters: The capital positions Strive to act on prospective deals if they arise, CEO Chris Riopelle tells Axios Pro. 

What they're saying: Riopelle didn't rule out future acquisitions.

"We want to be well-poised to be in a position to act if some opportunities present themselves," he says.

Follow the money: The round comprises $300 million in equity, led by NEA and joined by CVS Health Ventures, CapitalG, Echo Health Ventures and Town Hall Ventures.

Strive also added $100 million to its debt facility credit line from Hercules Capital, expanding it to $250 million.

What's next: Some of the capital will help Strive further expand into adjacent conditions such as congestive heart failure.

How it works: Strive works with payers, health systems and physicians to offer value-based, tech-enabled kidney care. It delivers care through a group of nurse practitioners, dietitians and care navigators. The company also helps patients access other types of condition-related care such as cardiology and endocrinology.

Strive partners with more than 700 nephrology providers and 6,500 total providers.

Catch up quick: NEA also led Strive's $166 million Series C raise announced in May 2023. 

Strive has raised approximately $700 million since it was founded in 2018.

State of play: Multiple companies focused on kidney care have raked in large funding rounds in recent years.

In January 2023, Monogram Health raised $375 million in new funding. The company focuses on patients with conditions including chronic kidney and end-stage renal disease.

Somatus raised $325 million in Series E funds in early 2022.

Strive Health raises $550M Series D

an illustration of George Washington peeking out from behind a star of life

Strive Health raised $550 million in a Series D funding round, valuing it at $1.8 billion.Why it matters: The capital positions Strive to act on prospective deals if they arise, CEO Chris Riopelle tells Axios Pro.

Strive Health raises $550M Series D

What to read next